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Abstract
Emphysematous gastritis is a rare, often fatal disease characterized by 
the presence of gas within the walls of the stomach and diffuse gastric 
wall inflammation due to gas-forming bacteria. Gastric mucormycosis is a 
rare manifestation of invasive fungal disease, ranging from colonization 
of peptic ulcers to infiltrative disease with vascular invasion and dissemi-
nation. The combination of the two conditions is rare. There are a few 
reports in the literature of invasive gastric mucormycosis associated with 
emphysematous gastritis that were fatal. Here, we present a case of inva-
sive gastric mucormycosis associated with emphysematous gastritis for 
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1. Introduction
Emphysematous gastritis is an often fatal, rare clinical 
entity consisting of gastric wall inflammation, sys-
temic toxicity, and the radiological appearance of air 
bubbles in the stomach walls secondary to gas pro-
duction by bacteria. Predisposing factors include in-
gestion of corrosive substances, alcohol abuse, recent 
abdominal surgery or gastroenteritis [1]. Prognosis is 
grave, with a reported mortality rate of 61%, which 
has remained constant since the earliest reports [2].
Mucormycosis is a term used for infections caused 
by molds of the order Mucorales. Certain conditions 
predispose to tissue invasion by these saprophytic 
fungi, including diabetes mellitus, metabolic acidosis, 
leukemia, lymphoma, corticosteroid therapy, severe 
malnutrition, organ transplantation, extensive burns, 
uremia, deferoxamine-based therapy, use of contam-
inated bandages and tongue depressors [3,4]. 
Mucormycosis is usually an acute, fulminant infection 
characterized pathologically by the invasion of major 
blood vessels, with resultant ischemia and infarction 
of adjacent tissue. Mixed infections with other fungi 
and bacteria are common. A recent review reported in 
the literature showed only 10 survivors out of 50 pri-
mary gastric mucormycosis cases [5].
Isolation of fungi from cases of emphysematous 
gastritis has been rare. Until now, there have been only 
a few reports of gastric mucormycosis associated 
with emphysematous gastritis found in the literature, 
and the results were fatal [6,7]. Here, we present a 
case of invasive gastric mucormycosis associated with 
emphysematous gastritis for which medical manage-
ment was successful.
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2. Case report
A 57-year-old man presented to our emergency de-
partment with fever, shortness of breath, and right 
upper quadrant pain. He had medical comorbidities 
of chronic hepatitis B and chronic obstructive pul-
monary disease with irregular steroid use. On admis-
sion, the laboratory data were: AST, 13,348 IU/L 
(< 41 IU/L); ALT, 7701 IU/L (< 41 IU/L); total bilirubin, 
2.6 mg/dL (< 1.2 mg/dL); blood urea nitrogen, 83 mg/
dL (< 20 mg/dL); creatinine, 5.5 mg/dL (< 1.2 mg/dL); 
white cell count, 26,590/μL (< 9600/μL); fibrin deg-
radation product, 28.8 μg/mL (< 5 μg/mL); and D-dimer, 
9126 ng/mL (< 500 ng/mL). Septic shock with multi-
organ failure, involving liver, kidney, lung and coagu-
lopathy was diagnosed. He was intubated for ventilation 
support.
Intravenous penicillin G 3 MU every 6 hours, levo-
floxacin 250 mg every other day, and cefepime 
1000 mg/day were used empirically. The antibiotics 
were shifted to intravenous meropenem 1000 mg 
every 12 hours and vancomycin 1000 mg every other 
day because of the persistent critical condition. 
Blood cultures showed no growth of bacteria or fun-
gus. Ventilator-associated pneumonia occurred later. 
Sputum cultures grew Staphylococcus aureus and 
Hemophillus influenzae.
On day 12 of admission, we found coffee-ground 
substance in the nasogastric tube. Esophago gastro-
duodenoscopy revealed a 6 × 7-cm round ulcer with a 
brown-greenish coating on the base over the greater 
curvature of the body (Fig. 1). Histology disclosed 
an ulcer with exudates, granulation tissue and fibrin 
deposits. No Helicobacter pylori was found. Under 
hematoxylin and eosin staining (400×, Fig. 2A) and 
Grocott’s methenamine silver staining (400×, Fig. 2B), 
many proliferating, nonseptate fungal hyphae with 
right angle branching were detected that were mor-
phologically consistent with mucormycosis. In addi-
tion, he had sphenoid sinusitis but no mucormyces 
was isolated from nasal sinus fluid.
Contrast-enhanced computed tomography of the 
abdomen showed a collection of intramural gas over 
the greater curvature side of the gastric body (Fig. 3). 
Surgical intervention was not performed due to the 
patient’s poor medical condition. A 21-day course of 
intravenous liposomal amphotericin B was adminis-
tered intravenously at a dose of 200 mg/day. The 
patient had a gradual recovery.
Fig. 1 — Endoscopic view showing a well-defined giant 
round ulcer with brown-greenish coating on the base 
over the greater curvature of the body.
A B
Fig. 2 — Histopathologic photomicrograph showing numer-
ous nonseptate hyphal elements with right angle branch-
ing indicative of mucormyces (arrows). (A) Hematoxylin 
and eosin stain (400´). (B) Grocott’s methenamine silver 
stain (400´).
Fig. 3 — Contrast-enhanced computed tomography of 
the abdomen showing a collection of intramural gas over 
the greater curvature side of the gastric body (arrows), 
indicative of emphysematous gastritis.
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Follow-up liver function showed rapid return to nor-
mal levels, which implied that the acute hepatitis 
was due to shock. Renal function had deteriorated to 
creatinine 10.0 mg/dL on the 9th day of admission, 
then gradually improved to normal levels 1 month after 
admission. The gastric ulcer healed 1 month after the 
episode, which was documented by esophagogas-
troduodenoscopy. The patient remained well during 
the 11-month follow-up period.
3. Discussion
Emphysematous gastritis is a rare fatal disorder. In 
patients with emphysematous gastritis, broad-spectrum 
antibiotics for Gram-negative rods and anaerobes 
should be administered. Indications for surgical inter-
vention include perforation, necrosis, ischemia, or fail-
ure of conservative management [2,8].
The most frequent sites of mucormycosis are the 
lungs (81%), central nervous system (27%), sinuses 
(16%), liver (16%) and orbital space (10%) [9]. The 
gastrointestinal tract was involved in only 7% of 
cases [10]. The most common gastrointestinal organ 
affected is the stomach (67%), followed by the colon 
(21%), small intestine (4%), and esophagus (2%) 
[10]. Abdominal pain and bloody diarrhea are two 
typical manifestations. Predisposing factors for inva-
sive gastric mucormycosis include malnutrition, renal 
insufficiency, im munosuppression, other infections, 
antibiotic use, and diabetes [10]. In our case, the 
patient suffered from chronic obstructive pulmonary 
disease with steroid use that rendered the patient 
susceptible to Mucorales infection. Furthermore, the 
most commonly associated condition is the presence 
of a preexisting gastric ulcer [11]. It is possible that 
the denuded gastric ulcer base in a compromised host 
allows the bacteria and fungi to invade deeply, leading 
to gastric wall necrosis and intramural gas production.
Definitive diagnosis of mucormycosis requires his-
topathologic evidence of fungal invasion of tissues [3]. 
The direct detection of fungus in tissues was signifi-
cantly more sensitive than in cultures [12]. Mucorales 
readily stains with periodic acid-Schiff, methenamine 
silver, and routine hematoxylin and eosin stains [4]. 
Histopathologic sections show broad (3–25 mm in 
diameter), thin-walled, mostly aseptate hyphae. Fre-
quently, these hyphae show focal bulbous dilation 
and nondichotomous, irregular branching that occa-
sionally occurs at right angles [3].
Making recommendations for treatment of gastric 
mucormycosis is difficult because it is a rare condi-
tion and is usually associated with a fatal outcome. 
The therapy of mucormycosis includes surgical deb-
ridement of all necrotic tissue, amphotericin B treat-
ment, and aggressive metabolic support [13]. Because 
mucormycosis is a highly angioinvasive infection 
with resulting extensive thrombosis and tissue necro-
sis, antifungal agents often display poor penetration at 
the site of the infection. Early surgical debridement 
of the infected tissue should be performed before the 
infection disseminates to other organs [3]. The mor-
tality rate was 55% in patients who received antifungal 
agents alone versus 27% in patients who received 
antifungal agents and underwent surgery for pulmo-
nary mucormycosis [14]. In our case, however, only 
medical treatment was given due to his poor medical 
condition, yet the patient survived.
In conclusion, we present a rare case of a patient 
who manifested a combination of emphysematous 
gastritis and gastric mucormycosis. The patient 
was successfully managed using intensive medical 
therapy.
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